iifl-logo

Pfizer Ltd Historical Data

5,249
(-3.98%)
Aug 26, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Pfizer Ltd Historical Data

26/07/2025calendar-icon
26/08/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

28-Jul-2025

5,374

5,3745,260.55,300.53,7408,65,74,574.59,864

29-Jul-2025

5,276.5

5,314.55,241.55,2773,1395,94,50,8625,601

30-Jul-2025

5,230.5

5,3105,230.55,260.55,6318,57,46,849.59,031

31-Jul-2025

5,230

5,233.55,1795,194.54,8697,97,63,868.59,035

01-Aug-2025

5,246

5,2465,0255,054.54,8517,58,13,3168,389

04-Aug-2025

5,000

5,034.54,9215,0097,72711,56,21,717.511,790

05-Aug-2025

5,047.5

5,1185,0095,090.54,8889,16,75,924.57,907

06-Aug-2025

5,092

5,1104,989.55,051.54,1467,48,03,760.58,173

07-Aug-2025

5,031.5

5,040.54,9405,0205,0218,86,75,0008,186

08-Aug-2025

5,005.5

5,0454,9604,9932,8285,84,01,3816,648

11-Aug-2025

4,995

5,2004,9155,060.53,7997,29,56,9327,092

12-Aug-2025

5,118

5,2005,0835,1029,29514,93,76,3669,784

13-Aug-2025

5,126

5,1475,0685,1073,5997,97,36,1437,761

14-Aug-2025

5,280

5,513.55,263.55,32870,3162,33,15,59,87048,867

18-Aug-2025

5,400

5,873.55,354.55,766.565,1772,35,21,74,8881,25,103

19-Aug-2025

5,712.5

5,7875,6305,698.517,07749,72,32,62622,232

20-Aug-2025

5,650

5,7025,6405,655.54,32010,54,16,965.57,911

21-Aug-2025

5,691

5,746.55,644.55,680.58,10515,85,92,00513,096

22-Aug-2025

5,693

5,7655,622.55,668.55,45414,12,51,0339,816

25-Aug-2025

5,670.5

5,697.55,4255,466.510,17923,71,38,703.521,040

26-Aug-2025

5,440

5,4465,227.55,2497,98425,02,31,067.522,355

Pfizer: Related NEWS

Pfizer India Q1 Profit Rises 27%; Unveils PCV20 Vaccine
14 Aug 2025|02:27 PM

Revenue also saw healthy growth. It was up 7.1% to ₹604 crore from ₹563 crore a year earlier.

Read More
Pfizer Partners with Mylan to Boost Ativan and Pacitane Sales in India
23 Feb 2025|11:51 PM

Ativan is a common medication used predominantly for anxiety disorders, whereas Pacitane is used for Parkinson’s disease and other neurological conditions.

Read More
Pfizer Ties Up with Mylan to Boost Ativan and Pacitane Sales in India
21 Feb 2025|05:31 PM

The agreement, which is discussed up to April and approved by Pfizer's Board of Directors, will be for five years, with discussions ending on 21 February 2025.

Read More
Pfizer India Q3 Profit Slips 2% YoY
31 Jan 2025|11:34 PM

Revenue from operations decline marginally by 0.4% YoY at ₹538 crore, as against ₹540 crore in Q3 FY24

Read More
Pfizer reports 61% YoY profit surge in Q1 2024
30 Jul 2024|09:44 AM

At the operating level, EBITDA increased by 60.2%, reaching ₹177.5 Crore in the first quarter of this fiscal year, compared to ₹110.8 Crore in the same quarter last year.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.